Virus Recombinant SARS-COV RBD 100 µg (from Mammalian Cells)
Supplier: ReVacc Scientific
Certificates
About this item
A recombinant form of the receptor binding domain (RBD with amino acids 334 to 516) of the spike (S) glycoprotein gene from severe acute respiratory syndrome-related coronavirus (2003 strain) (SARS-CoV), (GenBank: AY278554.2) was produced by human embryonic kidney HEK293F cells, followed by purification.
- Protein function: Bind to its receptor
This product contains C-terminal 8 hexa-histidine tag and HA tag.
This product has been run on SDS-PAGE with reduced condition. The binding of one control mAb and published 80R and CR3022 antibodies was tested in ELISAs.
Specifications
- Conjugation:Unconjugated
- Protein/Peptide Type:Recombinant
- Source:Mammalian cells
- Species:Virus
- Storage Conditions:–80 °C
- Gene ID:AY278554
- Endotoxin-free:N
- Carrier-Free:Y
- Protease-free:N
- Animal-Free:Y
- Protein Synonyms:SARS-COV spike receptor binding domain (His and HA Tags)
- Protein/Peptide Name:SARS-COV RBD
- Purity:75 - 100%
- Molecular Weight:~ 37 kDa
- Endotoxin Level:None detected
- Concentration:0.2 mg/ml
- Formulation:Frozen liquid. In PBS pH 7.5
- Nuclease-free:N
- Shipping Temperature:Dry Ice
- Tested Applications:ELISA, SDS-PAGE
Specifications
Frequently Bought Together